Log in to save to my catalogue
Log in to save to my catalogue

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised contro...

| Ask | Become a Library member

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised contro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_26185177

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlledtrial

About this item

Full title

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlledtrial

Author / Creator

HAUSCHILD, Axel , GROB, Jean-Jacques , MARTIN-ALGARRA, Salvador , KARASZEWSKA, Bogusiawa , MAUCH, Cornelia , CHIARION-SILENI, Vanna , MARTIN, Anne-Marie , SWANN, Suzanne , HANEY, Patricia , MIRAKHUR, Beloo , GUCKERT, Mary E , GOODMAN, Vicki , DEMIDOV, Lev V , CHAPMAN, Paul B , JOUARY, Thomas , GUTZMER, Ralf , MILLWARD, Michael , RUTKOWSKI, Piotr , BLANK, Christian U , MILLER, Wilson H and KAEMPGEN, Eckhart

Publisher

Kidlington: Elsevier

Journal title

The Lancet (British edition), 2012, Vol.380 (9839), p.358-365

Language

Russian

Formats

Articles

Publication information

Publisher

Kidlington: Elsevier

More information

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pascalfrancis_primary_26185177

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_26185177

Other Identifiers

ISSN

0140-6736

How to access this item

Log in as a Library member

Full text available

About resource

View in old catalogue

Connecting people and collections